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Edited by Horst FeldmannAbstract Here, we show for the ﬁrst time that Akt1 is cleaved
in vitro at the caspase-3 consensus site DQDD456 ﬂ SM. Our
data suggest QEEE116 ﬂ E117 ﬂMD, EEMD119ﬂ, TPPD453 ﬂ
QD and DAKE398 ﬂ IM as novel non-consensus caspase-3 cleav-
age sites. More importantly, we demonstrate that phosphoryla-
tion of Akt1 modulates its cleavage in a site-speciﬁc manner:
Resistance to cleavage at site DAKE398 (within the kinase
domain) in response to phosphorylation suggests a possible
mechanism by which the anti-apoptotic role of Akt1 is regulated.
Our result is important in biological models which rely on Akt1
for cell survival.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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hAkt1, a human oncogene [23,24], is implicated in a wide
variety of cellular processes including adipocyte and muscle
diﬀerentiation, glycogen synthesis, glucose uptake, apoptosis
and cellular proliferation [1,7,9,10,13]. Akt1 phosphorylates
p27, impairs the nuclear import of p27 and opposes cyto-
kine-mediated G1 arrest [18]. Over-expression of an activated
Akt1, but not of a kinase-deﬁcient mutant, provides protection
against apoptosis and results in a malignant phenotype, sug-
gesting that Akt1 activation is necessary and suﬃcient to inhi-
bit apoptosis and induce transformation [14]. Activation of
Akt1 involves phosphorylation on two regulatory sites: threo-
nine 308 and serine 473, both of which are required for maxi-
mal kinase activity [6].
We have previously demonstrated that Akt is a physiological
substrate of caspase-3 [2], the main executioner of cell death
[11,15,16,20]. Caspases are grouped into subfamilies according
to their preferred cleavage sites, with caspase-3 as the proto-
type of DEXD-dependent proteases [17,21]. Phosphorylation
renders caspase-3 substrates more resistant to caspase-3-medi-
ated proteolysis [3,8,12]. The exact site(s) of Akt1 cleavage has*Corresponding author. Address: Hormones, Growth and Develop-
ment Program, Ottawa Health Research Institute, 725 Parkdale
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doi:10.1016/j.febslet.2007.05.033not been identiﬁed, nor is the possible inﬂuence of phosphory-
lation on the cleavage. In this study, we investigated the cas-
pase-3 consensus and non-consensus cleavage sites in Akt1,
examined their speciﬁcity and compared the extent of cleavage
at these sites between phosphorylated and non-phosphorylated
Akt1 in vitro. Our data suggest that attenuation of caspase-3-
mediated Akt1 cleavage mediated by phosphorylation may be
a mechanism by which the activation of this survival pathway
is enhanced and that cleavage of the non-consensus site within
the kinase domain may be signiﬁcant in suppressing the func-
tion of Akt1.2. Methods
2.1. Reagents
Anti-Akt1/2 and recombinant (rec)-hAkt1, Akt2, and Akt3 were
purchased from Upstate (Lake Placid, NY). Anti-AKT and anti-
Akt3 were purchased from Cell Signaling Technology, Inc. (Beverly,
MA, USA). Rec-caspase-3 and its substrate Ac-(acetyl) DEVD-
MCA was from BD Biosciences Pharminogen (Mississauga, Ont.,
Canada). The MALDI-mass spectrum plates were purchased from Ap-
plied Biosystems (Foster City, CA, USA). Protein sequences of hAkt1
(Genebank Accession number AAH00479), hAkt2 (Genebank
Accession number AY056465) and hAkt3 (Genebank Accession
number NP035915) were obtained from NCBI.2.2. Caspase-3 activity assay
Ac-DEVD-MCA ﬂuorogenic substrate was incubated with active
rec-caspase-3 (0–200 ng) at 37 C in 100 lL of PIPES buﬀer. Free
AMC (7-amino 4-methyl coumarin) released was measured spectroﬂu-
orometrically at excitation and emission wavelengths ﬁxed at 370 and
460 nm, respectively.2.3. AKT cleavage assay and Western blot
All rec-proteins are of human sequence. Akt1 (125 ng) was incu-
bated with caspase-3 (40 ng for 0.5–4 h or 0–320 ng for 2 h). Akt1
was also incubated with caspase-3 (50 ng) in the absence and presence
of its inhibitor (DEVD-CHO, 20 pM) or DMSO (0.09%, control). To
compare the cleavage fragments of diﬀerent isoforms of AKT, Akt1,
Akt2 or Akt3 (125 ng each) were incubated with caspase-3 (0–80 ng).
To assess the inﬂuence of phosphorylation on cleavage, Akt1 and
phospho-Akt1 (125 ng each) were incubated with caspase-3 (40 ng;
37 C 0.5–4 h) in 40 ll of PIPES buﬀer, pH 7.0. We investigated the
pH dependence of Akt1 cleavage using a ternary buﬀer (30 mM
sodium acetate, 30 mM 2-[N-morpholino] ethane sulfonic acid and
30 mM N-ethylmorpholine) containing reagents necessary for opti-
mum caspase-3 activity (100 mM NaCl, 10% sucrose, 10 mM DTT,
and 0.1% CHAPS) at pH 3, 4, 5, 6, and 7. Akt1 was incubated with
caspase-3 at each pH to assess its pH-dependent degradation.
(Fig. 3C shows the pH-dependent cleavage of novel band A1/2.) Wes-
tern blot was performed as described [2].blished by Elsevier B.V. All rights reserved.
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All peptides were synthesized using Fmoc-solid phase peptide chem-
istry [4]. Following amino acid side chain protecting groups were used:
t-butyloxycarbonyl (Boc) for Lys; 2,2,4,6,7-pentamethyl dihydrobenzo
furan-5-sulphonyl (Pbf) for Arg; t-butyl for Ser, Thr, Asp and Tyr and
trityl for His, Asn and Gln. The peptide was puriﬁed by reversed-phase
high performance liquid chromatography (RP-HPLC, Rainin
Dynamax) using a semi-preparative column (CSC Exsil, C18,
25 cm · 1.0 cm, Chromatography Specialty Co., St-Laurent, Quebec,
Canada) [5]. Each puriﬁed peptide was characterized by amino acid
analysis and MALDI or SELDI-tof MS. using 4-hydroxycinnamic
acid or 1, 2 dihydroxy benzoic acid as matrix [4].3. Results
3.1. Akt1 Sequence analysis and cleavage at the consensus
sequence DQDD456
Examination of hAkt1 protein sequence (Genebank Acces-
sion number AAH00479) revealed the presence of a caspase-3-
consensus motif DQDD456. To examine whether this is indeed
a caspase-3 cleavage site, we incubated Akt1 for diﬀerent dura-
tions and with increasing caspase-3 concentrations and the lev-
els of the cleaved fragments were assessed by Western blot and
SELDI-tof mass spectrometry analyses. Since rec-Akt1 used in
the present study contains an N-terminal His6-tag (calculated
molecular mass 59 kDa), caspase-3-mediated Akt1 cleavage
at this site was expected to result in a 56.3 kDa N-terminus
and 2.7 kDa C-terminus fragments. Using N-terminus anti-
AKT antibody (epitope: PH domain), we detected a band at
57 kDa (band C) (Fig. 1A and B). The intensity of band C
increased with increasing caspase-3 concentrations or period
of digestion and was accompanied by a corresponding decrease
in Akt1 intensity. The presence of a caspase-3-inhibitor
(DEVD-CHO) resulted in complete disappearance of band C
(57 kDa) (Fig. 1C). Analysis of caspase-3-mediated Akt1
cleavage digests by SELDI-tof-MS, in search of the C-termi-
nus fragment, revealed a strong peak with a molecular mass
of 2.7 kDa (Fig. 1D). These data support caspase-3-mediatedFig. 1. Akt1 cleavage at the caspase-3 consensus motif DQDD456. Akt1 (125 n
and for diﬀerent durations (Panel B) or in the absence and presence of a caspa
PAGE. Akt1 was incubated with caspase-3 followed by analysis with SELDcleavage of Akt1 at the consensus DQDD456 site leading to a
C-terminal fragment of mass 2717. The peak at 2633 may
result from loss of N-terminal Ser residue during mass
spectrum.
3.2. Caspase-3-mediated Akt1 cleavage at non-consensus sites
Three additional bands were observed in SDS–PAGE follow-
ing analysis of caspase-3-digests of Akt1. The ﬁrst novel band
of 51 kDa (band B) was detected in concentration-response
and time course studies in which Akt1 was incubated with ac-
tive caspase-3 and immunoblotted with the ‘‘N-terminus’’
anti-AKT antibody (Fig. 2A and B). The band intensiﬁed with
increasing caspase-3 concentration and incubation duration
and was accompanied by a corresponding decreased intensity
of Akt1 substrate. Also band B disappeared completely in the
presence of the caspase-3 inhibitor DEVD-CHO (20 pM;
Fig. 2C), MS analysis of crude digest reveals the presence of
a peak around 9 kDa (Fig. 2D). Considering the size of the
intact Akt1 (59 kDa), the small 9 kDa peak, detected by
SELDI MS and the large 51 kDa fragment detected by electro-
phoresis complement each other to be the fragments generated
from cleavage at the same site (site B).
Two additional bands (A1 and A2) were detected in studies
in which Akt1 was incubated with active caspase-3 and immu-
noblotted with a ‘‘C-terminus’’ anti-Akt1 antibody (epitope:
467RPHFPQFSYSASSTA480). (Fig. 3A). Both bands were
completely eliminated in the presence of 20 pM of caspase-3
inhibitor (DEVD-CHO, Fig. 3B), implicating that bands A1
and A2 are Akt1 cleavage fragments possibly at the non-con-
sensus motif. Analysis of the digestion products by SELDI-tof
MS reveals presence of two peaks around 16 kDa (Fig. 3D).
Considering the size of the intact Akt1 (59 kDa), the small
16–16.5 kDa peaks (detected by SELDI-M.S.) and the large
42–43 kDa fragments (detected by electrophoresis) comple-
ment each other to be the fragments generated from cleavage
at identical sites (sites A1 and A2). Interestingly, the existence
of two distinct cleavage sites in close proximity to each other isg) was incubated with increasing concentrations of caspase-3 (Panel A)
se-3 inhibitor, DEVD-CHO (Panel C). Samples were analyzed by SDS–
I-MS (Panel D). Each panel represents the sum of ﬁve replicates.
Fig. 2. Akt1 cleavage at the non-consensus motif B: inﬂuence of phosphorylation. Akt1 (125 ng) was incubated with caspase-3 at diﬀerent
concentrations (Panel A) and duration (Panel B) or in the presence of caspase-3 inhibitor DEVD-CHO (Panel C). Samples were resolved on
SDS–PAGE and immunoblotted with an N-terminus anti-Akt1 antibody (Panels A–C) or analyzed by SELDI-tof MS (Panels D). Akt1 or its
phosphorylated counterpart were incubated with caspase-3 at the indicated time points (Panel E) Samples were analyzed by Western blot using
C-terminus and N-terminus Akt1 antibodies. Each panel shows a representative ﬁlter of 3–5 experiments.
Fig. 3. Akt1 cleavage at the non-consensus sites A1/A2: inﬂuence of phosphorylation. Caspase-3-mediated cleavage of Akt1 and phospho-Akt1 was
carried out as described in Figure. 2 with the diﬀerence that panels A–C and E were analyzed using only a C-terminus anti-Akt1 antibody. Panel C
shows the caspase-3 cleavage of Akt1 at various pHs.
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phorylated and phosphorylated Akt1 as described later.
3.3. Inﬂuence of phosphorylation on two novel cleavage sites: A
and B
When comparing the relative ability of Akt1 and its phos-
phorylated counterpart (p-Akt1) to serve as substrate for cas-
pase-3, our results indicate that phosphorylation of Akt1
inﬂuenced caspase-3-mediated cleavage in a site-speciﬁc man-
ner: whereas site A1 was more susceptible to cleavage in thephosphorylated Akt1 (Fig. 3E), the opposite was true for
cleavage at sites A2 and B (Figs. 2E and 3 E).
3.4. Digestion of Akt-1 peptides with caspase-3
Based on the SDS–PAGE and SELDI-MS analysis, we
propose EEEE117, EEMD119 and DAKE401 as novel cleav-
age sites giving rise to bands A1, A2 and B, respectively, in
the His-tagged fusion recombinant Akt1 protein. To further
examine this, we designed three peptides from the sequence
of hAkt-1 that encompass these potential caspase-3 cleavage
Fig. 4. SELDI-tof MS spectra proﬁle of crude digest of hAKT106–130 peptide by caspase-3 in the absence and presence of its inhibitor DEVD-CHO.
The mass spectrum was performed with 2 ll of sample with CHCA as matrix. Peaks corresponding to the undigested peptide (m/z = 2714) and one of
the major cleaved fragments (m/z = 1355) are indicated in the spectrum following 3 h incubation (Panels A). The proposed cleavage sites are shown in
vertical arrows. 106VAD GLKKQEEEE MDFRSGSPSD  NSG130  VADGLKKQEEEE with fragment MDFRSGSPSDNSG representing
the peak at 1355. SELDI-tof MS proﬁle of crude digest of hAkt peptide106–130 with excess caspase-3 at various durations is shown in (Panels B)
(b1 = full spectrum, b2 and b3 = expanded portion of the spectrum to highlight the cleaved peaks of the fragments). hAkt1106–130: VADGLKKQ-
EEE  EMD  FRSGSPSD  NSG-NH2 (MW = 2714)ﬁ VADGLKKQEEEEMD-OH (MW 1371, not observed), + FRSGSPSDNSG-NH2
(MW 1109), + VADGLKKQEEE-OH (MW 1245), + VADGLKKQEEEEMDFRSGSPSD-OH [MW 2456, 2478 (+Na)].
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FRSGSPSDNSG130 [calculated MW = 2712; observed
MW = 2714]; hAkt1385–410 + G: 385KKDPKQRLGGGSE-
DAKE  IMQHRFFAG410G [calculated MW = 2988; ob-
served MW = 2984] and hAkt1441–465: 441EFTAQMITIT
PPDQDD  SMECVDSER465 [calculated MW = 2859; ob-
served MW = 2860].
All peptides were digested for various durations (up to 18 h)
with similar level of caspase-3 activity and examined by
SELDI-tof MS for cleavages (Figs. 4 and 5). The matrix and
caspase-3 auto digest was used as control. Caspase-3 cleaves
synthetic hAkt1106–130 peptide at three positions: E117 M,
D119  F and D127  N (Fig. 4). This is conﬁrmed by the
appearance of peaks in the mass spectra at m/z 1355 and
2456 which are attributed to the fragments MDFRSG-
SPSDNSG (MW 1354) and VADGLKKQEEEEMDFRS-
GSPSD (MW 2455), respectively. When the same digestion
was repeated with excess caspase-3 for several time periods,
similar cleavages of Akt106–130 peptide was also noted
(Fig. 4B). Indeed, several other fragment peaks such as m/z
1109 and 1245 were observed corresponding to the fragments
FRSGSPSDNSG (MW 1109) and VADGLKKQEEE (MW
1245), respectively. These indicate the presence of two addi-
tional cleavage sites, namely EE ﬂ EMD ﬂ FR. Taken
together; we conclude that there are about ﬁve potential
cleavage sites within this peptide sequence as indicated
VAD ﬂ GLKKQEEE ﬂ E ﬂMD ﬂ FRSGSPSD ﬂ NSG.Digestion of hAkt1385–410 + G peptide with caspase-3 led to
the formation of two additional peaks at m/z 1470 and 2505 in
the mass spectra due to the presence of the fragments
PKQRLGGGSEDAKE and KKDPKQRLGGGSEDA-
KEIMQHR, respectively (Fig. 5A). This suggests cleavages
at KKD ﬂ PK, DAKE ﬂ IM and HR ﬂ FF. The ﬁrst two
cleavages are mediated by caspase-3 whereas the last cleavage
is possibly due to a trypsin-like enzyme present as a small con-
taminant in commercial caspase-3 sample. The extent of cleav-
age increases with duration of incubation.
Digestion of hAkt1441–465 peptide with caspase-3 yielded three
additional peaks atm/z 1055, 1257 (major) and 1820 in the mass
spectra due to the formation of fragments SMECVDSER,
QDDSMECVDSE and EFTAQMITITPPDQDD, respectively
(Fig. 5B). The peak atm/z 1842 is attributed to the Na-adduct of
fragment peak at m/z 1820. This suggests cleavages at EFTAQ-
MITITPPD ﬂ QDD ﬂ SMECVDSE ﬂ R by caspase-3. As ex-
pected the intensities of cleaved fragments at m/z 1257 and
1820 increase gradually with time of incubation.4. Discussion
Although analysis of the Akt1 protein sequence reveals pres-
ence of a caspase-3 consensus cleavage site DQDD456, the
presence of this site does not necessarily suggest its accessibility
to caspase-3 and subsequent binding, due to the presence of
Fig. 6. Caspase-3-mediated cleavage of Akt1, Akt2 and Akt3.
Akt1/2/3 were incubated with diﬀerent concentrations of caspase-3
(0-80 ng; 2 h; 37 C). Samples were analyzed by SDS–PAGE using
C-terminus anti-Akt1, -Akt2, and -Akt3 antibodies and N-terminus
anti-AKT, -Akt2, and -Akt3 antibodies. Each ﬁgure shows represen-
tative membrane of three experiments.
Fig. 5. SELDI-tof MS spectra proﬁle of hAkt1385–410 + G and hAkt1441–465. The mass spectrum was performed with 2 ll of sample with CHCA as
matrix. SELDI-tof MS of 18 h crude digest of hAkt1385–410 + G peptide with caspase-3 (Panels A). hAkt1385–410 + G: KKD  PKQRLGGGSE-
DAKE  IMQHR  FFAG-G (MW = 2988))KKD PKQRLGGGSEDAKE IMQHR (MW 2505) + PKQRLGGGSEDAKE (MW 1470).
SELDI-tof MS of crude digest of the hAkt1441–465 peptide with caspase-3 for various durations (Panels B). hAkt1441–465: EFTAQMITITPPD 
QDD  SMECVDSE  R-NH2 (MW = 2894)) EFTAQMITITPPDQDD (MW 1820), + SMECVDSE (MW 1055), + QDDSMECVDSE
(MW 1257).
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[22]. Phosphorylation could conceivably cause the ﬂap to open
or close further, thereby providing a potential regulatory
mechanism [19]. Since domain containing DQDD456 may fail
to dock in the catalytic site of caspase-3 due to steric hindrance
by the ﬂap, we ﬁrst investigated possibility of cleavage at this
site. Our Western blot and SELDI-MS data support cleavage
at the consensus site DQDD456 in vitro. The signiﬁcance of this
cleavage in the PI3K/AKT pathway remains unknown. Since
the consensus sequence DQDD456 is located at its C-terminus
end and cleavage at this site yields a novel Akt1 fragment with
only a 2.7 kDa diﬀerence in mass from intact Akt1, it is possi-
ble that this cleavage may have a minimal inﬂuence on the
activity and function of the protein.
In addition, we found several non-consensus motifs within
Akt1, all of which were conﬁrmed by synthesis of model pep-
tides and their subsequent cleavage with caspase-3. Compari-
son of the protein sequence of Akt1 with those of Akt2 and
Akt3 (gene bank) and the absence of the EEEE117, and
EEMD119 sites and presence of DAKE398 site in both Akt2
and Akt3 prompted us to perform a comparative study be-
tween these three isoforms. Our observation that incubation
of Akt2 and Akt3 with caspase-3 resulted in no cleavage frag-
ment similar to A1, and A2, while similar sites to cleavage site
B was detected in both Akt2 and Akt3 (Fig. 6) lends support
for the proposed cleavage model (Fig. 7).
In conclusion, we tested the hypothesis that attenuation of
caspase-3-mediated Akt1 cleavage via phosphorylation may
represent a mechanism by which the activation of this survival
pathway is enhanced. This was accomplished by comparing the
extent of cleavage between Akt1 and phospho-Akt1. We pro-pose that the cleavage at site B, located in the middle of the
two Akt1 activation/phosphorylation sites (Thr308 and Ser473)
and within the kinase domain of the protein, may be signiﬁcant
in suppressing the function of Akt1. Our data suggest that in
addition to regulating its kinase activity, phosphorylation of
Akt1 regulates its pattern of cleavage and inactivation by
caspsae-3. These two outcomes of Akt1 phosphorylation may
operate side by side to ensure cell endurance. The biological
Fig. 7. Proposed model for the caspase-3 cleavage sites in Akt1. In addition to the presence of a caspase-3 consensus sequence DQDD456 in human
Akt1, EEEE117, EEMD119, and DAKE398 are novel sites of cleavage for bands A1, A2, and B, respectively. The pair fragments of 2.7 and 53, 41.7
and 13.9, 41.4 and 14.1 and 9.2 and 46.4 kDa are expected cleavage fragments of human Akt1 at site DQDD456, EEEE117, EEMD119, and DAKE398,
respectively.
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